Search

everythinglearnresearchcommunity

for

Search:↓

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Father's finasteride use may affect son's fertility and testicular function.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Testosterone helps human pancreatic cells increase insulin release.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

PCOS may increase the risk of certain cancers.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

A holistic treatment approach, including yoga, diet, exercise, and mindfulness, can effectively manage PCOS symptoms.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Homoeopathic treatment may help manage polycystic ovarian syndrome.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Severe insulin resistance can be managed with medication, lifestyle changes, and treatment for related conditions.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

The conclusion is that women under 35 should start fertility checks after 12 months of trying to conceive, women over 35 after 6 months, and women over 40 should start immediately. The checks should include ovulation status, reproductive tract structure, and male partner's semen evaluation.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

People undergoing chemotherapy need better support and information to cope with hair loss.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.